Information: This is an outdated version of the data model. You can find a Versions overview via Versions on the left. You can find the newest Version by clicking here.
Information:
Error:
ID
5194
Description
NHL-BFM 2012 Registry. Principal Investigators: Birgit Burkhardt and Wilhelm Woessmann. NHL study group
Keywords
Versions (2)
- 5/15/14 5/15/14 - Martin Dugas
- 7/1/16 7/1/16 -
Uploaded on
May 15, 2014
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
NHL-BFM Registry 2012 Lymphoblastic Lymphoma
Similar models
Lymphoblastic Lymphoma
- StudyEvent: SE
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
CL Item
Pro-B (pre-pre-B) (B I) (3)
CL Item
Common (B II) (4)
CL Item
Pre-B (B III) (5)
CL Item
mature B (6)
CL Item
Pre-T (T II) (7)
CL Item
Cortical T (T III) (8)
CL Item
Medullary T (T IV) (9)
CL Item
Non-cortical-T (T V) (10)
CL Item
T-lineage, no subtyping possible (40)
CL Item
Mature T (41)
CL Item
Pro-T (T I) (42)
CL Item
bilineal / biphentotypic (50)
CL Item
B-lineage, no subtyping possible (60)
CL Item
Other (99)
Bilineal / biphenotypic: specify
Item
Bilineal / biphenotypic: specify
text
Other Diagnosis: specify
Item
Other Diagnosis: specify
text
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
no (1)
CL Item
yes (2)
Proliferation rate (%)
Item
Proliferation rate (%)
integer
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
negative (1)
CL Item
positive (2)
CL Item
surface (1)
CL Item
cytoplasmic (2)
CL Item
surface and cytoplasmic (3)
CL Item
not decidable, surface/cytoplasmic (4)
Additional antibody: specify
Item
Additional antibody: specify
text
CL Item
negative (1)
CL Item
positive (2)
CL Item
n.i. (not interpretable) (3)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
Additional antibody 1: specify
Item
Additional antibody 1: specify
text
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
Additional antibody 2: specify
Item
Additional antibody 2: specify
text
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
Additional antibody 3: specify
Item
Additional antibody 3: specify
text
CL Item
+++ (1)
CL Item
++ (2)
CL Item
+ (3)
CL Item
- (4)
CL Item
n.i. (not interpretable) (5)
Other characteristics / remarks
Item
Other characteristics / remarks
text